Cambrian Bio

www.cambrianbio.com
228 Park Avenue South, Suite 66643
New York, NY 10003

Company Info

Year Established
2019

Contacts

James Peyer, PhD
CEO

Company Description

Cambrian Bio (Cambrian BioPharma) is a clinical-stage drug development company focused on building therapeutics to treat and prevent today’s most debilitating chronic diseases, with programs targeting critical metabolic sensing functions that decline with age, including AMPK and mTOR.